Abstract
Micronutrients and trace elements have been identified to play an important role in the development of Parkinson’s disease (PD). In our previous study, we observed that prolidase activity is associated with oxidative stress and progression of PD. In present study, we aimed to study the association of prolidase-associated trace elements, such as Co, Mn, Ni, and Zn in the plasma of patients with PD by inductively coupled plasma spectrometry. Plasma levels of Co, Mn, and Ni were significantly increased, whereas plasma levels of Zn was significantly decreased (all P < 0.05) in the patients with PD than healthy controls. Plasma prolidase activity was not correlated to its associated trace elements in PD. A positive, linear, and significant correlation was observed between age and Co, and Mn, and Ni while negative and non-significant between age and status of Zn in the patients. Co, Mn, and Ni were continually elevated with increase in age as well as duration of disease in the patients with PD, whereas status of Zn was continually decreased. Thus, the study concluded that trace elements Co, Ni, and Mn status were increased and Zn status was decreased in the plasma of patients with PD. It is also concluded that elevated Co, Mn, and Ni has been associated with progression of Parkinson’s disease.
Similar content being viewed by others
References
Battaglia V, Compagnone A, Bandino A, Bragadinc M, Rossi CA, Zanetti F, Colombatto S, Grillo MA, Toninello A (2009) Cobalt induces oxidative stress in isolated liver mitochondria responsible for permeability transition and intrinsic apoptosis in hepatocyte primary cultures. Int J Biochem Cell Biol 41:586–594
Weber S, Dorman DC, Lash LH, Erikson K, Vrana KE, Aschner M (2002) Effect of manganese (Mn) on the develo** rat brain: oxidative stress related endpoints. Neuro-Toxicology 23:169–175
Kanninen KM, Grubman A, Meyerowitz J, et al. (2013) Increased zinc and manganese in parallel with neurodegeneration, synaptic protein changes and activation of Akt/GSK3 signaling in ovine CLN6 neuronal ceroid lipofuscinosis. PLoS One 8(3):1–10
Das KK, Das SN, Dhundasi SA (2008) Nickel, its adverse health effects & oxidative stress. Indian J Med Res 128:412–425
Xu SC, He MD, Zhong M, Zhang YW, Wang Y, Yang L, Yang J, Yu ZP, Zhou Z (2010) Melatonin protects against nickel-induced neurotoxicity in vitro by reducing oxidative stress and maintaining mitochondrial function. J Pineal Res 49(1):86–94
Plum LM, Rink L, Haase H (2010) The essential toxin: impact of zinc on human health. Int J Environ Res Public Health 7(4):1342–1365
Yaron A, Naider F (1993) Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 28(1):31–81
Kumari S, Verma AK, Rungta S, Mitra R, Srivastava R, Kumar N (2013) Serum prolidase activity, oxidant and antioxidant status in nonulcer dyspepsia and healthy volunteers. ISRN Biochemistry 2013; Article ID 182601: doi:10.1155/2013/182601
Du X, Tove S, Kast-Hutcheson K, Grunden AM (2005) Characterization of the dinuclear metal center of Pyrococcus furiosus prolidase by analysis of targeted mutants. FEBS Lett 579:6140–6146
Alberto ME, Leopoldini M, Russo N (2011) Can human prolidase enzyme use different metals for full catalytic activity? Inorg Chem 50:3394–3403
Verma AK, Chandra S, Singh RG, Singh TB, Srivastava S, Srivastava R (2014) Serum prolidase activity and oxidative stress in diabetic nephropathy and end stage renal disease: a correlative study with glucose and creatinine. Biochemistry Research International 2014; Article ID 291458, 7 pages
Miltyk W, Surazynski A, Kasprzak KS, Fivash Jr MJ, Buzard GS, Phang JM (2005) Inhibition of prolidase activity by nickel cause’s decreased growth of proline auxotrophic CHO cells. J Cell Biochem 94(6):1210–1217
Verma AK, Raj J, Sharma V, Singh TB, Srivastava S, Srivastava R (2015) Plasma prolidase activity and oxidative stress in patients with Parkinson’s disease. Parkinson’s Disease 2015: Article ID 598028, 6 pages. doi:10.1155/2015/598028
Afridi HI, Kazi TG, Kazi N, Shah AQ, Khan S, et al. (2012) Evaluation of calcium, magnesium, potassium, and sodium in biological samples (scalp hair, serum, blood, and urine) of Pakistani referents and arthritis patients of different age groups. Clinical Laboratory 58:7–18
Stabler SP, Allen RH (2004) Vitamin B12 deficiency as a worldwide problem. Annu Rev Nutr 24:299–326
Raghunathan VK, Devey M, Hawkins S, Hails L, Davis SA, Mann S, Chang IT, Ingham E, Malhas A, Vaux DJ, Lane JD, Case CP (2013) Influence of particle size and reactive oxygen species on cobalt chrome nanoparticle-mediated genotoxicity. Biomaterials 34(14):3559–3570
De Boecka M, Kirsch-Volders M, Lison D (2003) Cobalt and antimony: genotoxicity and carcinogenicity. Mutat Res 533:135–152
Goel RK, Bagga P (2010) Cobalt chloride induced histotoxic cerebral hypoxia: a new experimental model to study neuroprotective effect. J Pharm Educ Res 1(2):88–95
Fernsebner K, Zorn J, Kanawati B, Walker A, Michalke B (2014) Manganese leads to an increase in markers of oxidative stress as well as to a shift in the ratio of Fe(II)/(III) in rat brain tissue. Metallomics 6:921–931
Forte G, Bocca B, Senofonte O, Petrucci F, Brusa L, et al. (2004) Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson’s disease. J Neural Transm 111:1031–1040
Jiménez-Jiménez FJ, Molina JA, Aguilar MV, Meseguer I, Mateos-Vega CJ, et al. (1998) Cerebrospinal fluid levels of transition metals in patients with Parkinson’s disease. J Neural Transm 105:497–505
Fukushima T, Tan X, Luo Y, Kanda H (2011) Serum vitamins and heavy metals in blood and urine, and the correlations among them in Parkinson’s disease patients in China. Neuroepidemiology 36:240–244
Calderón-Garcidueñas L, Vojdani A, Blaurock-Busch E, Busch Y, Friedle A, Franco-Lira M, et al. (2015) Air pollution and children: neural and tight junction antibodies and combustion metals, the role of barrier breakdown and brain immunity in neurodegeneration. J Alzheimers Dis 43(3):1039–1058
Palacios N, Fitzgerald K, Roberts AL, Hart JE, Weisskopf MG, Schwarzschild MA, et al. (2014) A prospective analysis of airborne metal exposures and risk of Parkinson disease in the nurses’ health study cohort. Environ Health Perspect 122(9):933–938
Forsleff L, Schauss AG, Bier ID, Stuart S (1999) Evidence of functional zinc deficiency in Parkinson’s disease. J Altern Complement Med 5:57–64
Brewer GJ, Kanzer SH, Zimmerman EA, Molho ES, Celmins DF, et al. (2010) Subclinical zinc deficiency in Alzheimer’s disease and Parkinson’s disease. Am J Alzheimer’s Dis & Other Dementias 25:572–575
Ahmed SS, Santosh W (2010) Metallomic profiling and linkage map analysis of early Parkinson’s disease: a new insight to aluminum marker for the possible diagnosis. PLoS One 5:e11252
Nikam S, Nikam P, Ahaley SK, Sontakke AV (2009) Oxidative stress in Parkinson’s disease. Indian J Clin Biochem 24:98–101
Zhao H-W, Lin J, Wang X-B, Cheng X, Wang J-Y, Hu B-L, et al. (2013) Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson’s disease. PLoS One 8(12):e83060
Goulle JP, Mahieu L, Castermant J, et al. (2005) Metal and metalloid multi- elementary ICP-MS validation in whole blood, plasma, urine and hair: reference values. Forensic Sci Int 153(1):39–44
Acknowledgments
Facilities of ICP-OES spectrometry provided by Department of Chemical Engineering, IIT (BHU), are gratefully acknowledged. The authors are thankful to all the study subjects and the financial support provided by BHU. IMS-UGC-JRF/SRF fellowship received by AK Verma is highly acknowledged.
Conflict of Interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Verma, A.K., Keshari, A.K., Raj, J. et al. Prolidase-Associated Trace Elements (Mn, Zn, Co, and Ni) in the Patients with Parkinson’s Disease. Biol Trace Elem Res 171, 48–53 (2016). https://doi.org/10.1007/s12011-015-0503-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-015-0503-4